Harmony at Home: A Pilot Telehealth Program for Rural ADRD Caregivers
Creating Harmony at HOME: A Pilot Study of a Telehealth Based Program for Rural Caregivers' Ability to Adapt Home Environments for Adults With ADRD
2 other identifiers
interventional
80
1 country
1
Brief Summary
There is a need for caregiver-initiated and -implemented non-pharmacological interventions directly to and for the person with dementia, including environmental assessment and modification, as first-line treatments for behavioral and psychological symptoms of dementia (BPSD) in persons living with dementia (PLWD). Delivered via telehealth, Harmony at HOME (H@H) aims to train caregivers of persons with moderate to severe ADRD in the skills of assessing and modifying the home environment to promote "person-environment fit," a concept that posits that the ability to access features within a built environment (e.g. bathroom, stairs,) or that factors within the environment itself (lighting, noise level, temperature), especially when linked with individualized social support, contribute to or even shape behavior. In addition to the intervention, the first 10 caregiver participants to enroll will also be invited to participate in two focus groups that will be facilitated during and after the intervention. The first focus group focuses on experiences as a dementia caregiver in rural areas. The second focus group focuses on providing feedback regarding caregivers' perceptions, acceptability, and usefulness of the H@H intervention. These focus groups will be conducted as structured interviews with open-ended questions that encourage participants to share their experiences.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable alzheimer-disease
Started Jan 2022
Shorter than P25 for not_applicable alzheimer-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 7, 2022
CompletedStudy Start
First participant enrolled
January 15, 2022
CompletedFirst Posted
Study publicly available on registry
January 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 8, 2022
CompletedResults Posted
Study results publicly available
December 29, 2023
CompletedDecember 29, 2023
December 1, 2023
10 months
January 7, 2022
November 1, 2023
December 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Caregiver Mastery
Pearlin Mastery Scale: A 4-item scale measuring the extent to which a participant sees life as being under his/her personal control vs. something that is fatalistically ruled. Scores range from 4 to 16, with higher scores indicating greater levels of mastery.
baseline, visit 2 (week 6), visit 3 (week 10)
Other Outcomes (4)
Change in Caregiver Burden
Timeframe 10 weeks (baseline, 6 weeks, 4 week follow up)]
Change in Caregiver Stress
Timeframe 10 weeks (baseline, 6 weeks, 4 week follow up)]
Change in Caregiver Satisfaction
Timeframe 10 weeks (baseline, 6 weeks, 4 week follow up)
- +1 more other outcomes
Study Arms (1)
Harmony at HOME
EXPERIMENTALH@H is a 6-week telehealth intervention delivered by an occupational therapist during weekly visits.
Interventions
H@H is a 6-week telehealth intervention delivered by an occupational therapist during weekly visits.
Eligibility Criteria
You may qualify if:
- Caregiver for Participant with Dementia:
- Men or women aged 21-99, inclusive.
- Willingness and ability to participate in trial and implement recommended intervention strategies throughout the duration of the study.
- Access to and ability to use video technology (Zoom) for telehealth visits.
- English speaking, able to read and write.
- Ability to retrieve and return mail.
- Participants with Dementia:
- Men or women aged 65-99, inclusive.
- Living at home in the community with one primary caregiver.
- \. Diagnosis of Alzheimer's disease as primary dementia type of moderate to severe stages (confirmed by Clinical Dementia Rating Scale score of 1.0+)
- No change in medical condition for one month prior to screening visit
- No change in medications for 4 weeks prior to screening visit.
- If on psychotropic medication, the participant is at a point where dosage and treatment are stabilized for the duration of the study.
- Physically acceptable for this study as confirmed by medical history, physical exam, and clinical tests completed by medical professional (MD, APRN, PA or OT).
- Functional sensory abilities with or without aids (hearing, vision, smell, touch, taste)
- +5 more criteria
You may not qualify if:
- Caregiver for Participant with Dementia:
- Diagnosis of mild cognitive impairment or dementia.
- Severe psychological stress or active state of psychiatric conditions (severe depression, mania, hallucinations/delusions).
- Participants with Dementia:
- Unstable medical conditions within one month prior to screening visit such as poorly controlled blood pressure, diabetes, current cancer diagnosis, or breathing problems, etc.
- Wheelchair or bed bound.
- Residence in skilled nursing facility or facility-based care.
- Skin lesions or skin abnormalities throughout upper extremities.
- Allergies related to lotion or fragrance.
- Caregiver report of physically violent behaviors.
- Initiation of antipsychotic medication within 4 weeks prior to screening or unpredictable use of such medications
- Diagnosis of profound or total sensory altering disorders including macular degeneration, legal blindness, total deafness, severe peripheral neuropathy, anosmia.
- Major depression in past 12 months (DSM-IV criteria), major mental illness such as schizophrenia, bipolar disorder, personality disorders, or recent (in past 12 months) alcohol or substance abuse.
- Diagnosis or concern of epilepsy.
- Use of any investigational agents or devices within 30 days prior to screening.
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Elizabeth K Rhoduslead
- National Institute on Aging (NIA)collaborator
- Emory Universitycollaborator
Study Sites (1)
University of Kentucky
Lexington, Kentucky, 40506, United States
Related Publications (1)
Rhodus EK, Kryscio R, Jicha G, Baum C, Henley L, Fairchild V, Roberts C, Gibson A. Creating harmony at home via environmental cueing: A feasibility trial of a non-pharmacological intervention for rural caregivers of persons with dementia. Alzheimers Dement. 2025 Jul;21(7):e70405. doi: 10.1002/alz.70405.
PMID: 40621818DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Elizabeth Rhodus
- Organization
- University of Kentucky
Study Officials
- STUDY DIRECTOR
Gregory Jicha, MD, PhD
University of Kentucky
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 7, 2022
First Posted
January 21, 2022
Study Start
January 15, 2022
Primary Completion
November 1, 2022
Study Completion
December 8, 2022
Last Updated
December 29, 2023
Results First Posted
December 29, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share